| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.03 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | -0.078 | 0.03 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.065 | 0.03 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.072 | 0.03 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.07 | 0.03 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.04 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.04 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.05 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.069 | 0.05 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.065 | 0.05 |